69
Views
5
CrossRef citations to date
0
Altmetric
Original articles

Social functioning deficits in young people at risk for schizophrenia

, , , , &
Pages 678-685 | Received 28 Feb 2008, Published online: 06 Jul 2009

References

  • Bellack AS, Morrison RL, Wixted JT, Mueser KT. An analysis of social competence in schizophrenia. Br J Psychiatry 1990; 156: 809–818
  • Couture SM, Penn DL, Roberts DL. The functional significance of social cognition in schizophrenia: a review. Schizophr Bull 2006; 32(Suppl 1)44–63
  • Davidson M, Reichenberg A, Rabinowitz J, Weiser M, Kaplan Z, Mark M. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiatry 1999; 156: 1328–1335
  • Malmberg A, Lewis G, David A, Allebeck P. Premorbid adjustment and personality in people with schizophrenia. Br J Psychiatry 1998; 172: 308–313
  • Cannon M, Jones P, Gilvarry C, et al. Premorbid social functioning in schizophrenia and bipolar disorder: similarities and differences. Am J Psychiatry 1997; 154: 1544–1550
  • Dworkin RH, Bernstein G, Kaplansky LM, et al. Social competence and positive and negative symptoms: a longitudinal study of children and adolescents at risk for schizophrenia and affective disorder. Am J Psychiatry 1991; 148: 1182–1188
  • Dworkin RH, Lewis JA, Cornblatt BA, Erlenmeyer-Kimling L. Social competence deficits in adolescents at risk for schizophrenia. J Nerv Ment Dis 1994; 182: 103–108
  • Hans SL, Auerbach JG, Asarnow JR, Styr B, Marcus J. Social adjustment of adolescents at risk for schizophrenia: the Jerusalem Infant Development Study. J Am Acad Child Adolesc Psychiatry 2000; 39: 1406–1414
  • Häfner H, Maurer K, Ruhrmann S, et al. Early detection and secondary prevention of psychosis: facts and visions. Eur Arch Psychiatry Clin Neurosci 2004; 254: 117–128
  • Häfner H, Nowotny B, Löffler W, an der Heiden W, Maurer K. When and how does schizophrenia produce social deficits?. Eur Arch Psychiatry Clin Neurosci 1995; 246: 17–28
  • Hamilton SH, Edgell ET, Revicki DA, Breier A. Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sample. Int Clin Psychopharmacol 2000; 15: 245–255
  • Bond GR, Kim HW, Meyer PS, et al. Response to vocational rehabilitation during treatment with first- or second-generation antipsychotics. Psychiatr Serv 2004; 55: 59–66
  • Rosenheck RA, Leslie DL, Sindelar J, et al. Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia. Am J Psychiatry 2006; 163: 2080–2089
  • Pinkham AE, Penn DL, Perkins DO, Graham KA, Siegel M. Emotion perception and social skill over the course of psychosis: a comparison of individuals “at-risk” for psychosis and individuals with early and chronic schizophrenia spectrum illness. Cognit Neuropsychiatry 2007; 12: 198–212
  • Ballon JS, Kaur T, Marks II, Cadenhead KS. Social functioning in young people at risk for schizophrenia. Psychiatry Res 2007; 151: 29–35
  • Addington J, Penn D, Woods SW, Addington D, Perkins DO. Social functioning in individuals at clinical high risk for psychosis. Schizophr Res 2008; 99: 119–124
  • Yung AR, Phillips LJ, Yuen HP, et al. Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group. Schizophr Res 2003; 60: 21–32
  • Niendam TA, Bearden CE, Johnson JK, et al. Neurocognitive performance and functional disability in the psychosis prodrome. Schizophr Res 2006; 84: 100–111
  • Chung YS, Kang D-H, Shin NY, Yoo SY, Kwon JS. Deficit of theory of mind in individuals at ultra-high-risk for schizophrenia. Schizophr Res 2008; 99: 111–118
  • Yung AR, Yuen HP, McGorry PD, et al. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry 2005; 39: 964–971
  • Maxwell ME. Manual for the Family Interview for Genetic Studies (FIGS). Clinical Neurogenetics Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD 1992
  • First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders. Biometrics Research Department, New York State Psychiatric Institute, New York 1996
  • McGorry PD, Goodwin RJ, Stuart GW. The development, use, and reliability of the brief psychiatric rating scale (nursing modification): an assessment procedure for the nursing team in clinical and research settings. Compr Psychiatry 1988; 29: 575–587
  • Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261–276
  • Andreasen NC. The Scale of the Assessment of Positive Symptoms. University of Iowa, Iowa City 1984
  • Andreasen NC. The Scale of the Assessment of Negative Symptoms. University of Iowa, Iowa City 1983
  • Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278–296
  • Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32: 50–55
  • Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989; 46: 1006–1011
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
  • Kim JS, Lee YS. Validity of Short Forms of the Korean–Wechsler Adult Intelligence Scale. Korean J Clin Psychol 1995; 14: 111–116
  • Birchwood M, Smith J, Cochrane R, Wetton S, Copestake S. The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatry 1990; 157: 853–859
  • Häfner H, Maurer K, Löffler W, . Onset and early course of schizophrenia. Search for the causes of schizophrenia III, H Häfner, WF Gattaz, et al. Springer, Berlin 1995; 43–66
  • Jackson HJ, McGorry PD, Dudgeon P. Prodromal symptoms of schizophrenia in first-episode psychosis: prevalence and specificity. Compr Psychiatry 1995; 36: 241–250
  • Moller P, Husby R. The initial prodrome in schizophrenia: searching for naturalistic core dimensions of experience and behavior. Schizophr Bull 2000; 26: 217–232
  • Gourzis P, Katrivanou A, Beratis S. Symptomatology of the initial prodromal phase in schizophrenia. Schizophr Bull 2002; 28: 415–429
  • Asarnow JR. Children at risk for schizophrenia: converging lines of evidence. Schizophr Bull 1988; 14: 613–631
  • Gottesman I. Schizophrenia genesis: the origin of madness. Freeman, New York 1991
  • Cornblatt BA, Lenzenweger MF, Dworkin RH, Erlenmeyer-Kimling L. Childhood attentional dysfunctions predict social deficits in unaffected adults at risk for schizophrenia. Br J Psychiatry 1992; 161(Suppl 18)59–64
  • Kendler KS. Genetics of schizophrenia and related disorders: a review. Relatives at risk for mental disorder, DL Dunner, ES Gershon, JE Barrett. Raven Press, New York 1988; 247–266
  • Kendler KS. Familial aggregation of schizophrenia and schizophrenia spectrum disorders. Evaluation of conflicting results. Arch Gen Psychiatry 1988; 45: 377–383
  • Ingraham LJ, Kety SS. Schizophrenia spectrum disorders. Handbook of schizophrenia, volume 3: nosology, epidemiology and genetics of schizophrenia, MT Tsuang, JC Simpson. Elsevier, Amsterdam 1987; 117–137
  • Meehl PE. Schizotaxia, schizotypy, schizophrenia. Am Psychol 1962; 17: 827–838
  • Meehl PE. Schizotaxia revisited. Arch Gen Psychiatry 1989; 46: 935–944
  • Stone WS, Faraone SV, Seidman LJ, Olson EA, Tsuang MT. Searching for the liability to schizophrenia: concepts and methods underlying genetic high-risk studies of adolescents. J Child Adolesc Psychopharmacol 2005; 15: 403–417
  • Faraone SV, Green AI, Seidman LJ, Tsuang MT. “Schizotaxia”: clinical implications and new directions for research. Schizophr Bull 2001; 27: 1–18
  • Seidman LJ, Wencel HE. Genetically mediated brain abnormalities in schizophrenia. Curr Psychiatry Rep 2003; 5: 135–144
  • Dickerson F, Boronow JJ, Ringel N, Parente F. Neurocognitive deficits and social functioning in outpatients with schizophrenia. Schizophr Res 1996; 21: 75–83
  • McGlashan TH, Zipursky RB, Perkins D, et al. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 2006; 163: 790–799
  • McGorry PD, Yung AR, Phillips LJ, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 2002; 59: 921–928
  • Tsuang M. Schizophrenia: genes and environment. Biol Psychiatry 2000; 47: 210–220
  • Tienari P, Sorri A, Lahti I, et al. Genetic and psychosocial factors in schizophrenia: the Finnish Adoptive Family Study. Schizophr Bull 1987; 13: 477–484
  • Yung AR. Commentary: the schizophrenia prodrome: a high-risk concept. Schizophr Bull 2003; 29: 859–865
  • Nuechterlein KH, Dawson ME, Gitlin M, et al. Developmental processes in schizophrenic disorders: longitudinal studies of vulnerability and stress. Schizophr Bull 1992; 18: 387–425

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.